Despite the high-profile failures of two more stroke drugs in late-stage trials, biotech firms are persevering with new approaches and treatments.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Reynolds, B.A. et al. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255, 1707–1710 (1992).
Luskin, M.B. Restricted proliferation and migration of postnatally generated neurons derived from the forebrain subventricular zone. Neuron 11, 173–189 (1993).
Lois, C. et al. Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia. Proc. Natl. Acad. Sci. USA 90, 2074–2077 (1993).
Kolb, B. et al. Growth factor-stimulated generation of new cortical tissue and functional recovery after stroke damage to the motor cortex of rats. J. Cereb. Blood Flow Metab. 27, 983–987 (2006).
Author information
Authors and Affiliations
Related links
Rights and permissions
About this article
Cite this article
Garber, K. Stroke treatment—light at the end of the tunnel?. Nat Biotechnol 25, 838–840 (2007). https://doi.org/10.1038/nbt0807-838
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0807-838
This article is cited by
-
Recycled Translation: Repurposing Drugs for Stroke
Translational Stroke Research (2022)
-
New insights into the role of GABAergic inhibition during functional reorganization of the visual cortex post-lesion
e-Neuroforum (2014)
-
A Model of Cerebral Circulation Disorders Created by Staged Ligation of the Common Carotid Arteries
Bulletin of Experimental Biology and Medicine (2012)
